KOSDAQMachinery049950

meerecompanyIncorporated

₩10,450▲ 3.77%2026-11-18 close
Market Cap
₩92.1B
Turnover
₩100M
Volume
10K
Shares out.
8.8M
PER
16.5×
PBR
0.6×
EPS
₩529
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Display Equipment Recovery Sustains Quarterly Profits

meerecompanyIncorporated returned to quarterly operating profit in the first quarter of 2026 as display equipment orders were recognized as revenue, but whether the three years of operating losses from 2023 through 2025 have been fully reversed will be tested in the 2026 annual report.

  1. 1

    Third-quarter 2026 revenue was KRW 29.1 billion, up 209.3% year on year, and operating profit was KRW 4.97 billion, swinging from a loss in the same quarter of the prior year.

  2. 2

    Annual revenue fell from KRW 154.9 billion in 2022 to KRW 40.9 billion in 2025, when the operating loss was KRW 24.7 billion and the operating margin was -60.4%.

  3. 3

    Press coverage points to a recovery in display equipment orders, including a KRW 46.4 billion order from BOE secured in December 2025, as the driver of the 2026 rebound.

  4. 4

    The Revo-i surgical robot's designation as an innovative product in June 2026 and expanding semiconductor equipment supply for HBM processes are presented as the company's new growth pillars.

  5. 5

    Operating cash flow was negative KRW 13.8 billion in 2025, so the gap between quarterly profits and cash generation is a key point to monitor.

02

Business structure

meerecompanyIncorporated was founded in 1984 and listed on KOSDAQ in 2005. It produces precision processing equipment used in semiconductor and display manufacturing.

In the first nine months of 2023, the segment mix was 93% precision processing equipment for display and semiconductor production, 4% surgical robots and 3% touch panels.

Press coverage in 2026 put semiconductor wafer equipment at about 20% of semiconductor and display manufacturing equipment sales and surgical robots at 10% to 15% of total sales.

Within display equipment, the grinding equipment is cited as the core product, and a November 2026 report described it as holding the number one global market share. The main customers are Chinese panel makers including BOE, and the company said orders from them were recognized as third-quarter 2026 revenue.

Export share fell from 70.2% in 2023 to 49.6% in 2024 and 33% in 2025, according to Dealsite. On the semiconductor side, the company is expanding supply of ultra-precision processing equipment used in HBM and advanced packaging.

The Revo-i surgical robot was designated an innovative product by the Ministry of Trade, Industry and Energy in June 2026 and has been supplied to Mongolian national hospitals. A subsidiary consolidated from the second quarter of 2026 has started to add to consolidated revenue.

Compared with Sunic System, which focuses on OLED deposition equipment, the company combines precision processing with surgical robots.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩9.4B-₩5.4B−57.8%
2025Q4₩13.6B-₩5.7B−42.2%
2026Q1₩21.2B₩1.3B5.9%
2026Q2₩23.3B₩4.5B19.2%
2026Q3₩29.1B₩5B17.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩154.9B₩25.5B₩29.3B16.5%22.0%28.6%
2023₩109.5B-₩1.7B₩3.5B−1.6%2.7%16.5%
2024₩67.3B-₩16.8B-₩7.1B−25.0%−5.7%18.4%
2025₩40.9B-₩24.7B-₩25B−60.4%−24.7%20.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-11

04

Earnings analysis

Annual revenue fell from KRW 154.9 billion in 2022 to KRW 109.5 billion in 2023, a 29.3% decline, then to KRW 67.3 billion in 2024, down 38.5%, and to KRW 40.9 billion in 2025, down 39.2%.

Revenue has declined for three consecutive years from 2023 through 2025, with 2022 the largest year and 2025 the smallest in the 2022 to 2025 period.

Operating profit was KRW 25.5 billion in 2022, then turned into an operating loss of KRW 1.75 billion in 2023, and the losses widened to KRW 16.8 billion in 2024 and KRW 24.7 billion in 2025. The operating margin moved from 16.5% in 2022 to -1.6% in 2023, -25.0% in 2024 and -60.4% in 2025.

Net income attributable to controlling shareholders fell from KRW 29.3 billion in 2022 to KRW 3.54 billion in 2023, down 87.9%, then turned to a net loss of KRW 7.14 billion in 2024 and KRW 25 billion in 2025.

The 2025 net loss including non-controlling interests was also KRW 25 billion, the same figure as the loss attributable to controlling shareholders. Operating cash flow declined from KRW 10.7 billion in 2022 to negative KRW 1.08 billion in 2023, negative KRW 5.16 billion in 2024 and negative KRW 13.8 billion in 2025.

On a quarterly basis, the third quarter of 2025 had revenue of KRW 9.4 billion and an operating loss of KRW 5.43 billion. Revenue rose to KRW 13.6 billion in the fourth quarter of 2025, up 44.6% from the prior quarter, and to KRW 21.2 billion in the first quarter of 2026, up 55.7%.

Operating profit turned positive at KRW 1.26 billion in the first quarter of 2026. It then reached KRW 4.49 billion in the second quarter, up 257.3% from the prior quarter, and KRW 4.97 billion in the third quarter, up 10.7%, with operating profit rising for two consecutive quarters.

Net income attributable to controlling shareholders was KRW 3.8 billion in the first quarter of 2026, then declined for two consecutive quarters to KRW 3.6 billion in the second quarter, down 5.3%, and KRW 2.77 billion in the third quarter, down 23.1%.

Combined net income attributable to controlling shareholders over the four quarters from the fourth quarter of 2025 through the third quarter of 2026 was KRW 4.19 billion.

Revenue has recovered faster than profit, and third-quarter 2026 operating profit of KRW 4.97 billion remains below the KRW 25.5 billion operating profit recorded in 2022 on an annual basis.

05

Industry analysis

Demand for the company's core display equipment is directly linked to the capital spending cycle of panel makers.

In this equipment industry, the timing of customers' investment execution determines revenue more than technology, and new orders shrink sharply when panel makers delay line expansions or replacements of older tools.

Coverage describes display operations as having bottomed after large orders from China in 2025 and entering a recovery phase. BOE, CSOT and Visionox are investing in 8.6-generation OLED lines with local government subsidies, and LG Display announced plans for capital spending of about KRW 2.4 trillion in 2026.

On the semiconductor side, ultra-precision processing equipment for HBM and advanced packaging has moved into volume supply, according to the company. Sunic System, another listed display equipment company, focuses on OLED deposition equipment, so its product scope differs.

Surgical robots have expanded their clinical cases since their introduction at Severance Hospital in March 2023 and are spreading to domestic tertiary hospitals and export markets.

In competitive terms, the grinding equipment is described as the global number one, but 2025 revenue of KRW 40.9 billion is far below 2022 levels, leaving a scale recovery to complete.

Because the display capex downturn overlaps with the slow expansion of surgical robot sales, the pace at which new businesses offset core volatility will determine the company's position in its industry.

06

Outlook

A company official expected 2026 to be a year of modest recovery as Chinese panel makers resume 8.6-generation OLED investment. The order backlog rose from KRW 16.2 billion at the end of 2024 to KRW 60.0 billion at the end of 2025.

Third-quarter 2026 revenue of KRW 29.1 billion was reported as reflecting orders from major customers including Chinese panel makers. The company has presented expanded supply of ultra-precision processing equipment for HBM and advanced packaging as a medium- to long-term growth driver.

Consolidating the subsidiary adds to top-line size, but its contribution to profit needs to be confirmed in quarterly disclosures.

The Revo-i surgical robot has been designated an innovative product and supplied to Mongolia, and unit sales and consumables revenue will be the variables for the expansion of overseas references. In display, the pace of BOE and other panel makers' investment execution is the key variable for the next revenue trend.

Because operating cash flow was negative in 2025, it is also worth checking whether working capital and collections improve after the return to quarterly profits.

07

Valuation

PER
16.5×
PBR
0.6×
ROE
3.8%
EPS
₩529
BPS
₩14,019
Dividend per share
₩0

Earnings-based multiples are hard to compare with the historical PER band because net losses attributable to controlling shareholders continued through 2024 and 2025. The PER band formed during past profitable periods could regain meaning if quarterly profits continue in 2026.

On the price-to-book basis, the stock sits in a zone without a premium over net asset value, measured against the KRW 101.4 billion of equity attributable to controlling shareholders at the end of 2025.

The price-to-book comparison shows the gap between share price and net asset value, but because the switch from losses to profits is recent, interpretations may differ. The dividend yield is below the industry average, and dividend capacity is limited while losses continued.

The direction from a profitable 2022 to losses from 2023 through 2025, followed by quarterly profits in 2026, is not enough on its own to judge long-term earnings power. The valuation reading may change once the 2026 annual report confirms full-year operating margin and operating cash flow.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-11

08

Bull factors

Display order recovery reflected in quarterly results

Operating profit turned positive in the first quarter of 2026 and then rose for two consecutive quarters, with third-quarter revenue up 209.3% year on year.

The company secured a KRW 46.4 billion order from BOE in December 2025, and the order backlog rose from KRW 16.2 billion at the end of 2024 to KRW 60.0 billion at the end of 2025. Chinese panel makers' resumed 8.6-generation OLED investment is presented as the background.

Expansion into semiconductor equipment and HBM processes

The company says it is expanding supply of ultra-precision semiconductor processing equipment that is essential for HBM and advanced packaging. Press coverage in 2026 put semiconductor wafer equipment at about 20% of semiconductor and display manufacturing equipment sales. If that share grows, exposure to the display capex cycle could be spread across more businesses.

Surgical robot certification and overseas supply base

The innovative product designation and supply to hospitals in Mongolia feed into overseas references. Clinical cases have grown since its introduction at Severance Hospital in March 2023, building a performance record. More overseas references can support consumables revenue and unit sales growth.

09

Bear factors

Long-term contraction in revenue scale

Annual revenue fell from KRW 154.9 billion in 2022 to KRW 40.9 billion in 2025 and declined for three consecutive years from 2023. The operating margin was -60.4% in 2025, the widest loss in the period.

Even with higher quarterly revenue in 2026, the annual scale remains far below 2022, making the size of the recovery hard to gauge.

Gap between cash generation and profit

Operating cash flow deteriorated from KRW 10.7 billion in 2022 to negative KRW 13.8 billion in 2025. Quarterly profits returned in 2026, but net income attributable to controlling shareholders declined in both the second and third quarters. How much of the profit converts into cash has yet to be demonstrated.

Capex cycle dependence and limits of new businesses

Equipment revenue depends on when customers execute capex, and some coverage judges that new businesses have not expanded fast enough to offset core weakness. Surgical robot sales were reported at 10% to 15% of the total. The export share also fell from 70.2% in 2023 to 33% in 2025, showing a shift in customer mix alongside.

10

Risk factors

Industry and capex cycle

Orders fall directly when panel makers postpone capital spending. The consecutive revenue declines from 2023 through 2025 occurred during a downturn in this cycle. If Chinese panel makers delay resuming investment, the sustainability of quarterly profits in 2026 could weaken.

Customer concentration and order volatility

Key demand is concentrated among Chinese panel makers, so one customer's investment decisions can significantly affect revenue. Quarterly revenue can swing widely depending on the timing of large orders such as the December 2025 BOE order. Even with a year-end 2025 backlog of KRW 60.0 billion, delivery timing varies by quarter.

Financial and cash flow

Operating cash flow was negative KRW 13.8 billion in 2025, and net losses attributable to controlling shareholders continued in 2024 and 2025. Equity stood at KRW 101.4 billion at the end of 2025 and the debt ratio at 20.2%, so leverage is modest, but equity could shrink if losses persist. Annual cash flow and profit need to be confirmed in the 2026 annual report.

11

What to watch next

  1. End of December 2026

    Watch whether Chinese panel makers execute 8.6-generation OLED investment and whether new orders are disclosed before year-end. Whether these orders convert into 2027 revenue will determine how durable the display recovery is.

  2. End of March 2027 (annual report filing deadline)

    The 2026 annual report will confirm full-year revenue, operating margin, operating cash flow and net income attributable to controlling shareholders. Compare the year-end 2026 order backlog with the KRW 60.0 billion recorded at the end of 2025.

  3. May 15, 2027 (filing deadline for the first-quarter 2027 report)

    Check whether the operating profit trend that began in the first quarter of 2026 holds in the first quarter of 2027. Also review the profit contribution from the consolidated subsidiary and surgical robot unit sales.

  4. Unscheduled, from December 2026 onward

    Monitor overseas supply contracts for Revo-i and new semiconductor equipment order disclosures. These have no fixed schedule, so timing may change.

12

Overall view

meerecompanyIncorporated has kept posting quarterly operating profits, with third-quarter 2026 revenue of KRW 29.1 billion and operating profit of KRW 4.97 billion, and the company attributes this to the recovery in display equipment orders alongside expansion into semiconductor equipment and surgical robots.

On the other side, annual revenue fell from KRW 154.9 billion in 2022 to KRW 40.9 billion in 2025, and the KRW 24.7 billion operating loss and negative KRW 13.8 billion operating cash flow in 2025 show that the earnings base has not yet recovered.

Supporting factors include the rise in order backlog and the innovative product designation for Revo-i, while the dependence on the capex cycle and weaker cash generation are the main negatives.

Valuation is hard to compare on earnings multiples, and the price-to-book ratio and dividend yield sit at levels that differ from the industry average, so the read is best based on factual comparison.

The next checkpoints are the operating margin and operating cash flow in the 2026 annual report and whether quarterly profits hold in the first quarter of 2027. This report provides information only and does not include any investment opinion, buy or sell recommendation.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. supple.kr
  2. dailyinvest.kr
  3. m.thinkpool.com
  4. etoday.co.kr
  5. tradingkey.com
  6. judal.co.kr
  7. etoday.co.kr
  8. judal.co.kr
  9. etoday.co.kr
  10. specialtimes.co.kr
  11. comp.wisereport.co.kr
  12. alphasquare.co.kr
  13. comp.fnguide.com
  14. irobotnews.com
  15. ssl.pstatic.net
  16. valueline.co.kr
  17. dealsite.co.kr
  18. jobplanet.co.kr

Report written 2026-11-11 · Data as of 2026-11-10

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis